Search results for "DEXA"

showing 10 items of 264 documents

A Prospective Randomized Study of Corticosteroids as Adjuvant Drugs to Opioids in Advanced Cancer Patients

2007

This randomized controlled study evaluated the role of corticosteroids as adjuvants to opioid therapy in 76 advanced cancer patients with pain who requiring strong opioids. Patients were divided in 2 groups. Group O received conventional opioid treatment. Group OS received dexamethasone (8 mg orally) along with conventional treatment. Pain and symptom intensity, sense of well-being, and opioid escalation index and distress score were recorded at weekly intervals until death. No differences in pain intensity, opioid consumption, and opioid escalation index were found in 66 patients who survived 33 to 37 days. Corticosteroids did not provide significant additional analgesia to opioids, but p…

AdultMalecorticosteroidmedicine.medical_treatmentAnti-Inflammatory Agentslaw.invention03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled trial030502 gerontologylawNeoplasmsmedicineHumansProspective Studiesopioids in advanced cancer patientsprospective randomized studyProspective cohort studyDexamethasoneAgedPain MeasurementAged 80 and overAnalysis of VarianceChemotherapyadjuvant drugDose-Response Relationship Drugbusiness.industryPalliative CareGeneral MedicineMiddle AgedPain IntractableAnalgesics OpioidTreatment OutcomeOpioidChemotherapy Adjuvant030220 oncology & carcinogenesisAnesthesiaDrug Therapy CombinationFemale0305 other medical scienceCancer painbusinessAdjuvantFollow-Up Studiesmedicine.drugAmerican Journal of Hospice and Palliative Medicine®
researchProduct

Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.

2017

Summary We assessed the safety and efficacy of bortezomib, cyclophosphamide and dexamethasone (VCD) induction therapy in previously untreated multiple myeloma patients. A total of 414 patients received three 21-day cycles of VCD prior to autologous stem-cell transplantation (ASCT). Most common grade ≥3 adverse events were leucopenia (31·4%) and thrombocytopenia (6·8%). The overall response rate (ORR) by investigator-based assessment was 85·4%. Most patients (74%) underwent successful central laboratory-based molecular cytogenetic analysis. No clinically relevant differences in ORR post-induction were seen between patients with or without high-risk cytogenetic abnormalities (86·2% vs. 84·3%)…

AdultMalemedicine.medical_specialtyCyclophosphamideAdolescentPhases of clinical researchGastroenterologyRisk AssessmentTransplantation AutologousDexamethasoneBortezomib03 medical and health sciencesCytogeneticsYoung Adult0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAdverse effectCyclophosphamideMultiple myelomaDexamethasoneBortezomibbusiness.industryHematologyInduction ChemotherapyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryTransplantationConsolidation ChemotherapyRegimen030220 oncology & carcinogenesisFemalebusinessMultiple Myeloma030215 immunologymedicine.drugStem Cell TransplantationBritish journal of haematology
researchProduct

Reproducibility of Regional DEXA Examinations of Abdominal Fat and Lean Tissue

2013

<b><i>Objective: </i></b>The aim of this study was to develop and test the validity of a new repeatable method to delimit abdominal areas for follow-up of fat mass (FM) and lean tissue mass (LM) in DEXA examinations<i>. </i><b><i>Methods: </i></b>37 male volunteers underwent two DEXA examinations. Total body FM and LM measurements and corresponding abdominal measurements in a carefully defined region were calculated from the first scan. After repositioning of the subjects and a second scan, the delimited region was copied and the abdominal tissues re-calculated. <b><i>Results: </i></b>The mean LM of the abdo…

AdultMalemedicine.medical_specialtyDEXAHealth (social science)lcsh:TX341-641Mean differenceFat massYoung AdultAbsorptiometry PhotonAbdominal musclesPhysiology (medical)AbdomenAbdominal fatHumansMedicineObesityta315lcsh:RC620-627Reproducibilitybusiness.industryAbdominal fatReproducibility of ResultsLean tissueta3141Total bodyBody Fluid CompartmentsMiddle AgedReproducibilityConfidence intervalSurgerylcsh:Nutritional diseases. Deficiency diseasesAbdominal musclesBody CompositionOriginal ArticlebusinessNuclear medicinelcsh:Nutrition. Foods and food supplyObesity Facts
researchProduct

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppressi…

1987

AdultMalemedicine.medical_specialtyDepressive DisorderHypothalamo-Hypophyseal SystemBipolar DisorderHydrocortisonebusiness.industryCorticotropin-Releasing HormonePituitary-Adrenal SystemMiddle AgedPathophysiologyDexamethasoneCorticotropin-releasing hormoneEndocrinologyAdrenocorticotropic HormoneInternal medicinemedicineHumansFemalebusinessBiological PsychiatryDepression (differential diagnoses)Dexamethasonemedicine.drugBiological psychiatry
researchProduct

Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.

1984

Three-hour cortisol-profiles and cortisol responses to a 1 mg dose of dexamethasone were recorded in 31 depressed patients and nine controls. The data indicate that the likelihood of detecting non-suppressible cortisol concentrations after dexamethasone is significantly increased in depressed patients with a hypersecretion of cortisol. However, a considerable subsample of normosecretors shows abnormal DST results. Conversely, hypersecretion is often associated with dexamethasone suppression. In this study a 1 mg-DST did not reflect the adrenocortical activity with ultimate accuracy. Therefore any attempts which correlate psychopathological or biological data with pituitary-adrenal activity …

AdultMalemedicine.medical_specialtyHydrocortisoneDexamethasoneInternal medicinemedicineHumansCircadian rhythmDexamethasoneAgedPsychiatric Status Rating ScalesDepressive DisorderBiological activityMiddle AgedCircadian RhythmPsychiatry and Mental healthSleep deprivationDexamethasone suppressionEndocrinologyDexamethasone suppression testFemalemedicine.symptomBiological psychiatryPsychologyPsychopathologymedicine.drugActa psychiatrica Scandinavica
researchProduct

Computerized brain tomography measures compared with spontaneous and suppressed plasma cortisol levels in major depression.

1989

We determined brain density and ventricular measurements with computerized tomography (CT) in 33 depressed patients and compared the results with basal plasma cortisol and its suppressibility by dexamethasone. Mean plasma cortisol was positively related to elevated ventricular brain ratio (VBR). No association could be found between dexamethasone suppression test (DST) status and VBR or any other CT parameter. Elevated plasma cortisol levels and increased VBRs were positively correlated with total scores on the Brief Psychiatric Rating Scale, the Global Assessment Scale and the Bech-Rafaelsen Melancholia Scale, but they were not significantly correlated with total score on the Hamilton Anxi…

AdultMalemedicine.medical_specialtyHydrocortisoneEndocrinology Diabetes and MetabolismDexamethasoneCerebral VentriclesBasal (phylogenetics)EndocrinologyInternal medicineMelancholiaBrief Psychiatric Rating ScalemedicineHumansBiological PsychiatryDexamethasoneDepression (differential diagnoses)HydrocortisonePsychiatric Status Rating ScalesDepressive DisorderEndocrine and Autonomic SystemsBrainMiddle AgedVentricular-brain ratioPsychiatry and Mental healthEndocrinologyDexamethasone suppression testFemalemedicine.symptomPsychologyTomography X-Ray Computedmedicine.drugPsychoneuroendocrinology
researchProduct

Multisteroid analysis after DST in depressed patients — A controlled study

1986

Abstract 111 consecutively admitted in-patients with a depressive syndrome received a dexamethasone suppresion test (DST) after all known factors which might confound the test results had been carefully excluded. Plasma concentrations of cortisol, corticosterone and dexamethasone were compared with several diagnostic evaluations (RDC, DSM-III, ICD-9) in a controlled study. The positive predictive value of nonsuppressed corticosteroid levels was only moderate for each diagnostic category. Diagnostic specificities were 84.6% for major depression, endogenous subtype (RDC), 71.2% for melancholia (DSM-III) and 86.8% for endogenous depression (IDC-9) when using a post-DST cortisol value above 50 …

AdultMalemedicine.medical_specialtyHydrocortisonemedicine.drug_classDexamethasonechemistry.chemical_compoundCorticosteroneInternal medicineMelancholiamedicineHumansDepression (differential diagnoses)DexamethasoneAgedDepressive DisorderMiddle AgedAntidepressive AgentsPsychiatry and Mental healthClinical PsychologyEndocrinologychemistryDexamethasone suppression testEndogenous depressionCorticosteroidFemaleMajor Diagnostic Categorymedicine.symptomCorticosteronePsychologymedicine.drugJournal of Affective Disorders
researchProduct

Therapeutic synergism between hyaluronic acid and dexamethasone in the intra-articular treatment of osteoarthritis of the knee: a preliminary open st…

1992

In vitro studies on the effects of dexamethasone on human synovial cells have shown that with high concentrations of the steroid in the culture medium cellular activity was completely blocked whereas with low concentrations (10(-6)M), cellular density decreased but there was an increase in the synthesis of RNA, DNA, protein and hyaluronic acid. These data, coupled with clinical experience of using intra-articular hyaluronic acid to treat patients with osteoarthritis of the knee, prompted the investigators to carry out an open, randomized study of the use of very small doses of dexamethasone in association with hyaluronic acid in 40 osteoarthritic patients. Twenty patients received a weekly …

AdultMalemedicine.medical_specialtyKnee Jointmedicine.drug_classmedicine.medical_treatmentSodium hyaluronatePainOsteoarthritismedicine.disease_causeDexamethasoneDrug Administration ScheduleInjections Intra-ArticularWeight-bearinglaw.inventionchemistry.chemical_compoundRandomized controlled triallawOsteoarthritisHyaluronic acidmedicineHumansHyaluronic AcidDexamethasoneAgedPain MeasurementChemotherapybusiness.industryDrug SynergismGeneral MedicineMiddle Agedmedicine.diseaseSurgeryMolecular WeightchemistryAnesthesiaCorticosteroidFemalebusinessmedicine.drugCurrent Medical Research and Opinion
researchProduct

Aggressive Pharmacological Treatment for Reversing Malignant Bowel Obstruction

2004

Early and intensive pharmacological treatment not only may reduce gastrointestinal symptoms but also reverse malignant bowel obstruction. Fifteen consecutive advanced cancer patients with inoperable bowel obstruction received a combination of drugs including metoclopramide, octreotide, dexamethasone and an initial bolus of amidotrizoato. Recovery of intestinal transit was reported within 1-5 days in fourteen patients, who continued this treatment without presenting symptoms of bowel obstruction until death. This case series establishes that the combination of propulsive and antisecretive agents can act synergistically to allow a fast recovery of bowel transit without inducing unpleasant col…

AdultMalemedicine.medical_specialtyMetoclopramidemedicine.drug_classOctreotideGastroenterologyBolus (medicine)Gastrointestinal AgentsInternal medicineEdemamedicineHumansGeneral NursingDexamethasoneAgedPelvic NeoplasmsTerminal Carebusiness.industrydigestive oral and skin physiologyPalliative CareFecal impactionDrug SynergismRecovery of FunctionMiddle Agedmedicine.diseasedigestive system diseasesBowel obstructionDrug CombinationsAnesthesiology and Pain MedicineTreatment OutcomeAnesthesiaAbdominal NeoplasmsCorticosteroidAntiemeticsFemaleNeurology (clinical)medicine.symptombusinessIntestinal Obstructionmedicine.drug
researchProduct

The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome

2017

Cushing syndrome (CS) is characterized by increased morbidity and mortality compared to the general population. However, there are patients who have more clinical aggressive forms than others. Aim of the study is to evaluate whether the degree of hypercortisolism, defined by the number of times urinary free cortisol (UFC) levels exceed the upper limit of the normal range (ULN), is related to the worsening of phenotypic features, as well as metabolic and cardiovascular parameters, in a cohort of CS patients. A cross-sectional study was conducted on 192 patients with active CS, consecutively presenting at the outpatients' clinic of the University Hospitals of Ancona, Naples, and Palermo. Pati…

AdultMalemedicine.medical_specialtyPediatricsHydrocortisoneEndocrinology Diabetes and MetabolismUrinary systemCushing hypercortisolismPopulationCushing syndrome severity030209 endocrinology & metabolismGastroenterologySeverity of Illness IndexDexamethasoneUrinary free cortisolSettore MED/13 - Endocrinologia03 medical and health sciencesCushing syndromeYoung Adult0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicineUrinary free cortisolmedicineHumanseducationCushing SyndromeCushing syndrome comorbiditieeducation.field_of_studyS syndromebusiness.industryDegree of hypercortisolismMiddle Agedmedicine.diseaseCross-Sectional Studies030220 oncology & carcinogenesisDexamethasone suppression testCohortFemalebusiness
researchProduct